المؤلفون: Zhong H; Department of Respiratory and Critical Care Medicine, Shanghai Chest Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China., Sun S; Department of Oncology, The Fifth Medical Center of PLA General Hospital, Beijing, China., Chen J; Department of Thoracic Oncology, Hunan Cancer Hospital, Changsha, China., Wang Z; Department of Thoracic Oncology, Peking University Cancer Hospital and Institute, Beijing, China., Zhao Y; Department of Oncology, Henan Cancer Hospital, Zhengzhou, China., Zhang G; Department of Respiratory, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China., Chen G; First Ward of Respiratory Medicine, Harbin Medical University Cancer Hospital, Harbin, China., Zhou M; Department of Thoracic Surgery, Affiliated Cancer Hospital and Institute of Guangzhou Medical University, Guangzhou, China., Zhou J; Department of Respiratory, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China., Du Y; Department of Oncology, The First Affiliated Hospital of Anhui Medical University, Hefei, China., Wu L; Department of Thoracic Oncology, Hunan Cancer Hospital, Changsha, China., Xu Z; Department of Respiratory, Xinqiao Hospital of Army Medical University, Chongqing, China., Mei X; Department of Respiratory and Critical Care Medicine, Anhui Provincial Hospital, Heifei, China., Zhang W; Department of Respiratory, Hunan Provincial People's Hospital, Changsha, China., He J; Department of Oncology, Huai'an First People's Hospital, Huai'an, China., Cui J; Department of Oncology, The First Hospital of Jilin University, Changchun, China., Zhang Z; Department of Respiratory, Anhui Cancer Hospital, Hefei, China., Luo H; Department of Thoracic Oncology Radiotherapy, Jiangxi Cancer Hospital, Nanchang, China., Liu W; Department of Respiratory and Critical Care Medicine, The First Affiliated Hospital of Gannan Medical University, Ganzhou, China., Sun M; Department of Oncology, Jinan Central Hospital, Jinan, China., Wu J; Department of Oncology, The First Affiliated Hospital of Xiamen University, Xiamen, China., Shen Y; Department of Respiratory and Critical Care Medicine, West China Hospital of Sichuan University, Chengdu, China., Zhang S; Department of Oncology, Beijing Chest Hospital, Capital Medical University, Beijing, China., Yang N; Department of Medical Oncology, Lung Cancer and Gastrointestinal Unit, Hunan Cancer Hospital, Changsha, China., Wang M; Department of Respiratory and Critical Care Medicine, Peking Union Medical College Hospital, Beijing, China., Lu J; Department of Respiratory, Nantong Tumor Hospital, Nantong, China., Li K; Department of Thoracic Oncology, Tianjin Medical University Cancer Hospital, Tianjin, China., Yao W; Department of Oncology, Jiangxi Provincial People's Hospital, Nanchang, China., Sun Q; Department of Oncology, Henan Provincial Chest Hospital, Zhengzhou, China., Yue H; Department of Respiratory and Critical Care Medicine, The First Hospital of Lanzhou University, Lanzhou, China., Wang L; Department of Oncology, Hainan General Hospital, Haikou, China., Ye S; Department of Oncology, The First Affiliated Hospital of Sun Yat sen University, Guangzhou, China., Li B; Department of Oncology, Xiangya Hospital of Central South University, Changsha, China., Zhuang X; Department of Respiratory and Critical Care Medicine, Quanzhou First Hospital, Quanzhou, China., Pan Y; Department of Chemotherapy Oncology, Anhui Provincial Hospital, Hefei, China., Zhang M; Department of Respiratory and Critical Care Medicine, Ganzhou People's Hospital, Ganzhou, China., Shu Y; Department of Oncology, Jiangsu Province Hospital, Nanjing, China., He Z; Department of Thoracic Oncology, Fujian Cancer Hospital, Fuzhou, China., Pan L; Department of Respiratory and Critical Care Medicine, Beijing Shijitan Hospital, CMU, Beijing, China., Ling Y; Department of Oncology, Changzhou Cancer Hospital, Changzhou, China., Liu S; Department of Respiratory and Critical Care Medicine, The First Affiliated Hospital of Jinan University, Guangzhou, China., Zhang Q; Department of Respiratory, The First Hospital of Jiaxing, Jiaxing, China., Jiao S; Department of Oncology, The Fifth Medical Center of PLA General Hospital, Beijing, China. Electronic address: jiaosc@vip.sina.com., Han B; Department of Respiratory and Critical Care Medicine, Shanghai Chest Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China. Electronic address: hanbaohui@csco.org.cn.

المصدر: The Lancet. Respiratory medicine [Lancet Respir Med] 2024 May; Vol. 12 (5), pp. 355-365. Date of Electronic Publication: 2024 Jan 31.

نوع المنشور: Journal Article; Randomized Controlled Trial; Multicenter Study; Research Support, Non-U.S. Gov't; Clinical Trial, Phase III

بيانات الدورية: Publisher: Elsevier Country of Publication: England NLM ID: 101605555 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2213-2619 (Electronic) Linking ISSN: 22132600 NLM ISO Abbreviation: Lancet Respir Med Subsets: MEDLINE

مواضيع طبية MeSH: Paclitaxel*/administration & dosage , Paclitaxel*/therapeutic use , Carcinoma, Non-Small-Cell Lung*/drug therapy , Carcinoma, Non-Small-Cell Lung*/pathology , Lung Neoplasms*/drug therapy , Lung Neoplasms*/pathology , Carboplatin*/administration & dosage , Carboplatin*/therapeutic use , Antineoplastic Combined Chemotherapy Protocols*/therapeutic use, Humans ; Male ; Middle Aged ; Female ; Double-Blind Method ; Aged ; China ; Adult ; Antibodies, Monoclonal, Humanized/therapeutic use ; Antibodies, Monoclonal, Humanized/administration & dosage ; Treatment Outcome ; Progression-Free Survival

المؤلفون: Wang M; Peking Union Medical College Hospital, Beijing, China. Electronic address: mengzhaowang@sina.com., Fan Y; Zhejiang Cancer Hospital, Hangzhou, China., Sun M; Jinan Central Hospital, Jinan, China., Wang Y; West China Hospital of Sichuan University, Chengdu, China., Zhao Y; Affiliated Cancer Hospital of Zhengzhou University, Zhengzhou, China., Jin B; The First Hospital of China Medical University, Shenyang, China., Hu Y; Beijing Chest Hospital, Capital Medical University, Beijing, China., Han Z; The Affiliated Cancer Hospital of Xinjiang Medical University, Xinjiang, China., Song X; Shanxi Provincial Cancer Hospital, Taiyuan, China., Liu A; The Second Affiliated Hospital of Nanchang University, Nanchang, China., Tang K; The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China., Ding C; The Fourth Hospital of Hebei Medical University, Shijiazhuang, China., Liang L; Peking University Third Hospital, Beijing, China., Wu L; Hunan Cancer Hospital, Changsha, China., Gao J; The Affiliated Hospital of Inner Mongolia Medical University, Hohhot, China., Wang J; Chongqing University Cancer Hospital, Chongqing, China., Cheng Y; Jilin Cancer Hospital, Changchun, China., Zhou J; The First Affiliated Hospital Zhejiang University School of Medicine, Hangzhou, China., He Y; Army Medical Center of PLA, Chongqing, China., Dong X; Union Hospital Tongji Medical College Huazhong University of Science and Technology, Wuhan, China., Yao Y; The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China., Yu Y; Harbin Medical University Cancer Hospital, Harbin, China., Wang H; Fudan University Shanghai Cancer Center, Shanghai, China., Sun S; Fudan University Shanghai Cancer Center, Shanghai, China., Huang J; The First Affiliated Hospital of Soochow University, Suzhou, China., Fang J; Beijing Cancer Hospital, Beijing, China., Li W; The Second Affiliated Hospital Zhejiang University School of Medicine, Hangzhou, China., Wang L; Hainan General Hospital, Haikou, China., Ren X; Tianjin Medical University Cancer Institute & Hospital, Tianjin, China., Zhou C; The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, China., Hu Y; Hubei Cancer Hospital, Wuhan, China., Zhao D; The Second Hospital of Anhui Medical University, Hefei, China., Yang R; Yunnan Cancer Hospital, Kunming, China., Xu F; The First Affiliated Hospital of Nanchang University, Nanchang, China., Huang Y; Hainan Cancer Hospital, Haikou, China., Pan Y; Anhui Provincial Hospital, Hefei, China., Cui J; The Bethune First Hospital of Jilin University, Changchun, China., Xu Y; Peking Union Medical College Hospital, Beijing, China., Yang Z; Dizal Pharmaceutical, Shanghai, China. Electronic address: pamela.yang@dizalpharma.com., Shi Y; Cancer Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China.

المصدر: The Lancet. Respiratory medicine [Lancet Respir Med] 2024 Mar; Vol. 12 (3), pp. 217-224. Date of Electronic Publication: 2023 Dec 12.

نوع المنشور: Clinical Trial, Phase II; Multicenter Study; Journal Article

بيانات الدورية: Publisher: Elsevier Country of Publication: England NLM ID: 101605555 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2213-2619 (Electronic) Linking ISSN: 22132600 NLM ISO Abbreviation: Lancet Respir Med Subsets: MEDLINE

مواضيع طبية MeSH: Carcinoma, Non-Small-Cell Lung*/drug therapy , Carcinoma, Non-Small-Cell Lung*/genetics , Lung Neoplasms*/drug therapy , Lung Neoplasms*/genetics , Anemia*, Adult ; Humans ; Mutagenesis, Insertional ; China ; ErbB Receptors/genetics ; Exons/genetics

المؤلفون: Zhou Q; Guangdong Lung Cancer Institute, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Guangzhou, China., Zhao J; Beijing Cancer Hospital, Beijing, China., Chang J; Fudan University Shanghai Cancer Center, Shanghai, China., Wang H; Fudan University Shanghai Cancer Center, Shanghai, China., Fan Y; Zhejiang Cancer Hospital, Hangzhou, China., Wang K; West China Hospital Sichuan University, Chengdu, China., Wu G; Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China., Nian W; Chongqing Cancer Hospital, Chongqing, China., Sun Y; Jinan Central Hospital, Jinan, China., Sun M; Jinan Central Hospital, Jinan, China., Wang X; First Affiliated Hospital of Gannan Medical University, Ganzhou, China., Shi H; First Affiliated Hospital of Gannan Medical University, Ganzhou, China., Zheng X; Tianjin Medical University Cancer Institute & Hospital, Tianjin, China., Yao S; CStone Pharmaceuticals (Su Zhou) Co., Ltd., Suzhou, China., Qin M; CStone Pharmaceuticals (Su Zhou) Co., Ltd., Suzhou, China., Shen Z; CStone Pharmaceuticals (Su Zhou) Co., Ltd., Suzhou, China., Yang J; CStone Pharmaceuticals (Su Zhou) Co., Ltd., Suzhou, China., Wu YL; Guangdong Lung Cancer Institute, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Guangzhou, China.

المصدر: Cancer [Cancer] 2023 Oct 15; Vol. 129 (20), pp. 3239-3251. Date of Electronic Publication: 2023 Jun 06.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Wiley Country of Publication: United States NLM ID: 0374236 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1097-0142 (Electronic) Linking ISSN: 0008543X NLM ISO Abbreviation: Cancer Subsets: MEDLINE

مواضيع طبية MeSH: Carcinoma, Non-Small-Cell Lung*/drug therapy , Carcinoma, Non-Small-Cell Lung*/genetics , Lung Neoplasms*/drug therapy , Lung Neoplasms*/genetics, Adult ; Humans ; Pyridines/therapeutic use ; Pyrazoles/therapeutic use ; Protein Kinase Inhibitors/adverse effects ; Proto-Oncogene Proteins c-ret

المؤلفون: Yang C; Department of Oncology, Central Hospital Affiliated to Shandong First Medical University, Jinan City, China., Liang Y; Department of Radiation, The Second Affiliated Hospital of Xingtai Medical College, Xing Tai Shi, China., Liu N; Department of Oncology, Central Hospital Affiliated to Shandong First Medical University, Jinan City, China., Sun M; Department of Oncology, Central Hospital Affiliated to Shandong First Medical University, Jinan City, China. zhaniu2011@126.com.

المصدر: Radiation oncology (London, England) [Radiat Oncol] 2023 Sep 04; Vol. 18 (1), pp. 145. Date of Electronic Publication: 2023 Sep 04.

نوع المنشور: Journal Article; Review

بيانات الدورية: Publisher: BioMed Central Country of Publication: England NLM ID: 101265111 Publication Model: Electronic Cited Medium: Internet ISSN: 1748-717X (Electronic) Linking ISSN: 1748717X NLM ISO Abbreviation: Radiat Oncol Subsets: MEDLINE

مواضيع طبية MeSH: Carcinoma, Non-Small-Cell Lung*/radiotherapy , Lung Neoplasms*/radiotherapy , Radiation Oncology*, Humans ; CD8-Positive T-Lymphocytes ; Nucleotidyltransferases

المؤلفون: Lu S; Department of Medical Oncology, Shanghai Chest Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China. Electronic address: shunlu@sjtu.edu.cn., Wu L; Department of Thoracic Medical Oncology, Hunan Cancer Hospital and the Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha, China., Jian H; Department of Medical Oncology, Shanghai Chest Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China., Cheng Y; Department of Oncology, Jilin Cancer Hospital, Changchun, China., Wang Q; Department of Respiratory Medicine, Henan Cancer Hospital, Zhengzhou, China., Fang J; Department of Thoracic Medical Oncology, Peking University Cancer Hospital, Beijing Cancer Hospital, Beijing, China., Wang Z; Department of Thoracic Medical Oncology, Peking University Cancer Hospital, Beijing Cancer Hospital, Beijing, China., Hu Y; Department of Thoracic Medical Oncology, Hubei Cancer Hospital, Wuhan, China., Han L; Department of Oncology, Xuzhou Central Hospital, Xuzhou, China., Sun M; Department of Oncology, Jinan Central Hospital affiliated to Shandong University, Jinan, China., Miao L; Department of Respiratory Medicine, Nanjing University Medical School affiliated Nanjing Drum Tower Hospital, Nanjing, China., Ding C; Department of Respiratory Medicine, Hebei Medical University Fourth Affiliated Hospital and Hebei Provincial Tumor Hospital, Shijiazhuang, China., Cui J; Department of Oncology, First Hospital of Jilin University, Changchun, China., Wang K; Department of Respiratory Medicine, Sichuan University West China Hospital, Chengdu, China., Li B; Department of Oncology, Beijing Chest Hospital, Capital Medical University, Beijing Tuberculosis and Thoracic Tumor Research Institute, Beijing, China., Li X; Department of Oncology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China., Ye F; Department of Oncology, The First Affiliated Hospital of Xiamen University, Xiamen, China., Liu A; Department of Oncology, The Second Affiliated Hospital of Nanchang University, Nanchang, China., Pan Y; Department of Oncology, Anhui Provincial Hospital, Heifei, China., Cang S; Department of Oncology, Henan Provincial People's Hospital, Zhengzhou, China., Zhou H; Department of Medical Science and Oncology, Innovent Biologics, Suzhou, China., Sun X; Department of Biostatistics and Information, Innovent Biologics, Suzhou, China., Shen Y; Department of Medical Science and Oncology, Innovent Biologics, Suzhou, China., Wang S; Department of Medical Science and Oncology, Innovent Biologics, Suzhou, China., Zhang W; Department of Biostatistics and Information, Innovent Biologics, Suzhou, China., He Y; Department of Medical Science and Oncology, Innovent Biologics, Suzhou, China.

المصدر: The Lancet. Respiratory medicine [Lancet Respir Med] 2023 Jul; Vol. 11 (7), pp. 624-636. Date of Electronic Publication: 2023 May 05.

نوع المنشور: Randomized Controlled Trial; Clinical Trial, Phase III; Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Elsevier Country of Publication: England NLM ID: 101605555 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2213-2619 (Electronic) Linking ISSN: 22132600 NLM ISO Abbreviation: Lancet Respir Med Subsets: MEDLINE

مواضيع طبية MeSH: Carcinoma, Non-Small-Cell Lung*/drug therapy , Carcinoma, Non-Small-Cell Lung*/genetics , Lung Neoplasms*/drug therapy , Lung Neoplasms*/genetics, Humans ; Cisplatin ; Pemetrexed ; China ; Disease Progression ; ErbB Receptors/genetics ; Tyrosine/therapeutic use ; Antineoplastic Combined Chemotherapy Protocols/therapeutic use ; Double-Blind Method

المؤلفون: Zhou C; Department of Oncology, Shanghai Pulmonary Hospital, School of Medicine Tongji University, Shanghai, China. caicunzhoudr@163.com., Wang Z; Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Thoracic Oncology, Peking University Cancer Hospital and Institute, Beijing, China., Sun M; Department of Oncology, Jinan Central Hospital Affiliated to Shandong University, Jinan, China., Cao L; Department of Respiratory Medicine, The First Affiliated Hospital of University of Science and Technology of China, Division of Life Sciences and Medicine, University of Science and Technology of China, Anhui Provincial Hospital, Hefei, China., Ma Z; Department of Respiratory Medicine, The Affiliated Cancer Hospital of Zhengzhou University, Henan Cancer Hospital, Zhengzhou, China., Wu R; Department of Oncology, Shengjing Hospital of China Medical University, Huaxiang Branch Hospital, Shenyang, China., Yu Y; Department of Respiratory Medicine, Harbin Medical University Cancer Hospital, Harbin, China., Yao W; Thoracic Oncology, Sichuan Cancer Hospital and Institute, Chengdu, China., Sun S; Department of Oncology, Fudan University Shanghai Cancer Centre, Shanghai, China., Chen J; Department of Thoracic Oncology, Hunan Cancer Hospital, Changsha, China., Zhuang W; Department of Thoracic Oncology, Fujian Provincial Cancer Hospital, Fuzhou, China., Cui J; Pharmacology Base, The First Hospital of Jilin University, Changchun, China., Chen X; Department of Thoracic Oncology, Affiliated Hangzhou First People's Hospital, Zhejiang University School of Medicine, Zhejiang University Cancer Centre, Hangzhou, China., Lu Y; Department of Thoracic Oncology, West China Hospital, Sichuan University, Chengdu, China., Shen H; Department of Oncology, The Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, China., Hu C; Department of Oncology, The Second Xiangya Hospital of Central South University, Changsha, China., Liu J; Department of Oncology, The First Affiliated Hospital of Dalian Medical University, Dalian, China., Liu Y; Department of Medical Oncology, The First Hospital of China Medical University, Shenyang, China., Wang M; Department of Respiratory and Critical Care Medicine, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China., Li X; Department of Medical Oncology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China., Sun P; Department of Oncology, Yantai Yuhuangding Hospital, Yantai, China., Shu Y; Medical Oncology, Jiangsu Province Hospital, Nanjing, China., Zhou J; Department of Respiratory Disease, Thoracic Disease Centre, The First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, China., Li J; Department of Oncology, Liuzhou General Hospital, Liuzhou, China., Gu K; Department of Medical Oncology, The First Affiliated Hospital of Anhui Medical University, Hefei, China., Wang C; Department of Lung Cancer, Tianjin Medical University Cancer Institute and Hospital, Tianjin, China., Zhao H; Department of Respiratory Medicine, The Second Hospital of Anhui Medical University, Hefei, China., Zhang Y; Department of Medical Oncology, Zhejiang Cancer Hospital, Hangzhou, China., Liu C; The Second Department of Pulmonary Medicine, The Affiliated Cancer Hospital of Xinjiang Medical University, Urumqi, China., Wang J; Clinical Development, CStone Pharmaceuticals, Suzhou, China., Chen R; Clinical Development, CStone Pharmaceuticals, Suzhou, China., Qin M; Clinical Development, CStone Pharmaceuticals, Suzhou, China., Wang H; Clinical Development, CStone Pharmaceuticals, Suzhou, China., Yang J; Clinical Development, CStone Pharmaceuticals, Suzhou, China.

المصدر: Nature cancer [Nat Cancer] 2023 Jun; Vol. 4 (6), pp. 860-871. Date of Electronic Publication: 2023 Jun 15.

نوع المنشور: Randomized Controlled Trial; Clinical Trial, Phase III; Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101761119 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2662-1347 (Electronic) Linking ISSN: 26621347 NLM ISO Abbreviation: Nat Cancer Subsets: MEDLINE

مواضيع طبية MeSH: Carcinoma, Non-Small-Cell Lung*/drug therapy , Lung Neoplasms*/genetics, Humans ; Protein-Tyrosine Kinases/therapeutic use ; Proto-Oncogene Proteins/therapeutic use ; Survival Analysis ; Antineoplastic Combined Chemotherapy Protocols/adverse effects

المؤلفون: Yang S; Department of Medical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing Key Laboratory of Clinical Study on Anticancer Molecular Targeted Drugs, Beijing, People's Republic of China., Wu S; Department of Respiratory Medicine, The First Hospital of Shanxi Medical University, Taiyuan, People's Republic of China., Zhao Y; Department of Respiratory Medicine, The Affiliated Cancer Hospital of Zhengzhou University, Zhengzhou, People's Republic of China., Chen G; Department of Respiratory Medicine, Harbin Medical University Cancer Hospital, Harbin, People's Republic of China., Zhu B; Department of Oncology, Institute of Cancer, Xinqiao Hospital, Third Military Medical University, Chongqing, People's Republic of China., Li X; Department of Oncology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, People's Republic of China., Wang K; Department of Respiratory and Critical Care Medicine, West China Hospital of Sichuan University, Chengdu, People's Republic of China., Shi J; Department of Medical Oncology, Linyi Cancer Hospital, Linyi, People's Republic of China., Cang S; Department of Medical Oncology, Henan Provincial People's Hospital, Zhengzhou, People's Republic of China., Yao W; Department of Medical Oncology, Sichuan Cancer Hospital, Chengdu, People's Republic of China., Fan Y; Department of Medical Oncology, Zhejiang Cancer Hospital, Hangzhou, People's Republic of China., Fang J; Department of Thoracic Oncology, Beijing Cancer Hospital, Beijing, People's Republic of China., Zhang L; Department of Medical Oncology, Yantai Yuhuangding Hospital, Yantai, People's Republic of China., Zhou J; Department of Respiratory Medicine, The First Affiliated Hospital, Zhejiang University, School of Medicine, Hangzhou, People's Republic of China., Wu L; Department of Thoracic Medical Oncology, Hunan Cancer Hospital/The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha, People's Republic of China., Zheng R; Department of Medical Oncology, The First Affiliated Hospital of Bengbu Medical College, Bengbu, People's Republic of China., Huang M; Thoracic Oncology Ward, Division of Medical Oncology, West China Hospital, Sichuan University, Chengdu, People's Republic of China., Pan Y; Department of Thoracic Cancer Chemotherapy, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, People's Republic of China., Yang Z; Cancer Center, Affiliated Hospital of Guangdong Medical University, Zhanjiang, People's Republic of China., Sun M; Department of Oncology, Jinan Central Hospital Shandong University, Jinan, People's Republic of China., Yu H; Department of Palliative Care, Department of Geriatric Oncology, Chongqing University Cancer Hospital, Chongqing, People's Republic of China., Wang D; Department of Palliative Care, Department of Geriatric Oncology, Chongqing University Cancer Hospital, Chongqing, People's Republic of China., Huang J; Department of Respiratory and Critical Care Medicine, The First Affiliated Hospital of Soochow University, Suzhou, People's Republic of China., Wang L; Cancer Center, The Second Affiliated Hospital of Xingtai Medical College, Xingtai, People's Republic of China., Shu Y; Department of Oncology, Jiangsu Province Hospital, Nanjing, People's Republic of China., Chen Z; Department of Oncology, People's Hospital of Deyang City, Deyang, People's Republic of China., Liu C; Pulmonary Cancer Medicine, Affiliated Tumor Hospital of Xinjiang Medical University, Urumqi, People's Republic of China., Li J; Department of Oncology, Liuzhou People's Hospital, Liuzhou, People's Republic of China., Liu J; Department of Oncology, The First Affiliated Hospital of Dalian Medical University, Dalian, People's Republic of China., Sun S; Department of Respiratory Medicine, Third Xiangya Hospital of Central South University, Changsha, People's Republic of China., Guo Y; Department of Medical Oncology, The First Affiliated Hospital of Henan University of Science & Technology, Luoyang, People's Republic of China., Meng Z; Department of Respiratory Medicine, The Affiliated Huaian No. 1 People's Hospital of Nanjing Medical University, Huaian, People's Republic of China., Liu Z; Department of Oncology, Chinese PLA General Hospital, Beijing, People's Republic of China., Han Z; Pulmonary Cancer Medicine, Affiliated Tumor Hospital of Xinjiang Medical University, Urumqi, People's Republic of China., Wu G; Cancer Center, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, People's Republic of China., Lu H; Department of Oncology, Huaihe Hospital of Henan University, Kaifeng, People's Republic of China., Ma R; Department of Thoracic Oncology, Liaoning Cancer Hospital & Institute, Shenyang, People's Republic of China., Hu S; Department of Thoracic Oncology, Hubei Cancer Hospital, Wuhan, People's Republic of China., Zhao G; Department of Thoracic Surgery, Hwa Mei Hospital, University of Chinese Academy of Sciences, Ningbo, People's Republic of China., Zhang L; Department of Radiotherapy, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, People's Republic of China., Liu Z; Department of Oncology, HanDan Central Hospital, Handan, People's Republic of China., Xie C; Department of Radiotherapy, The 1st Affiliated Hospital of Wenzhou Medical University, Wenzhou, People's Republic of China., Zhong D; Department of Medical Oncology, Tianjin Medical University General Hospital, Tianjin, People's Republic of China., Zhao H; Department of Respiratory Medicine, The Second Hospital of Anhui Medical University, Hefei, People's Republic of China., Bi M; Department of Medical Oncology, The First Affiliated Hospital of Bengbu Medical College, Bengbu, People's Republic of China., Yi S; Department of Medical Oncology, Zhengzhou Central Hospital Affiliated to Zhengzhou University, Zhengzhou, People's Republic of China., Guo S; Department of Respiratory Medicine, The First Affiliated Hospital of Chongqing Medical University, Chongqing, People's Republic of China., Yi T; Department of Oncology, Xiangyang Central Hospital, Affiliated Hospital of Hubei University of Arts and Sciences, Xiangyang, People's Republic of China., Li W; Department of Respiratory and Critical Care Medicine, The Second Affiliated Hospital Zhejiang University School of Medicine. Hangzhou, People's Republic of China., Lin Y; Department of Medical Oncology, Cancer Hospital of Shantou University Medical College, Shantou, People's Republic of China., Chen Z; Department of Oncology, The Second Hospital of Anhui Medical University, Hefei, People's Republic of China., Zhuang Z; Department of Oncology, The Second Affiliated Hospital of Soochow University, Suzhou, People's Republic of China., Guo Z; Department of Respiratory Medicine, Shanghai East Hospital, Shanghai, People's Republic of China., Greco M; Department of Drug Discovery, Beta Pharma Inc., Princeton, NJ, USA., Wang T; Department of Clinical Development, Beta Pharma (Shanghai) Co., Ltd., Shanghai, People's Republic of China., Zhou A; Department of Clinical Development, Beta Pharma (Shanghai) Co., Ltd., Shanghai, People's Republic of China., Shi Y; Department of Medical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing Key Laboratory of Clinical Study on Anticancer Molecular Targeted Drugs, Beijing, People's Republic of China. Electronic address: syuankai@cicams.ac.cn.

المصدر: Lung cancer (Amsterdam, Netherlands) [Lung Cancer] 2023 Jun; Vol. 180, pp. 107194. Date of Electronic Publication: 2023 Apr 17.

نوع المنشور: Journal Article; Meta-Analysis; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Elsevier Scientific Publishers Country of Publication: Ireland NLM ID: 8800805 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1872-8332 (Electronic) Linking ISSN: 01695002 NLM ISO Abbreviation: Lung Cancer Subsets: MEDLINE

مواضيع طبية MeSH: Antineoplastic Agents*/therapeutic use , Antineoplastic Agents*/pharmacology , Carcinoma, Non-Small-Cell Lung*/drug therapy , Carcinoma, Non-Small-Cell Lung*/genetics , Carcinoma, Non-Small-Cell Lung*/pathology , Lung Neoplasms*/drug therapy , Lung Neoplasms*/genetics , Lung Neoplasms*/pathology, Humans ; Aniline Compounds/therapeutic use ; Central Nervous System/pathology ; ErbB Receptors/genetics ; Mutation ; Protein Kinase Inhibitors/therapeutic use ; Protein Kinase Inhibitors/pharmacology

المؤلفون: Zhao J; Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Thoracic Oncology, Peking University Cancer Hospital and Institute, Beijing, China., Yu X; Department of Medical Oncology, Cancer Hospital of University of Chinese Academy of Sciences & Zhejiang Cancer Hospital, Hangzhou, China., Huang D; Department of Thoracic Medical Oncology, Tianjin Cancer Hospital, Tianjin, China., Ma Z; Department of Medical Oncology, The Affiliated Cancer Hospital of Zhengzhou University; Henan Cancer Hospital, Zhengzhou, China., Gao B; Blacktown Hospital and University of Sydney, Sydney, New South Wales, Australia., Cui J; Cancer Center, The First Hospital of Jilin University, Changchun, China., Chu Q; Department of Oncology, Tongji Hospital, Wuhan, China., Zhou Q; Guangdong Lung Cancer Institute, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Guangzhou, China., Sun M; Department of Oncology, Jinan Central Hospital, Shandong University, Jinan, China., Day D; Medical Oncology, Monash Health and Monash University, Melbourne, Victoria, Australia., Wu J; Department of Medical Oncology, The First Affiliated Hospital of Xiamen University, Xiamen, China., Pan H; Department of Medical Oncology, Sir Run Run Shaw Hospital, Zhejiang University, Hangzhou, China., Wang L; Nanjing Drum Tower Hospital, Nanjing, China., Voskoboynik M; Medical Oncology, Nucleus Network, Melbourne, VIC, Australia and Central Clinical School, Monash University, Melbourne, Victoria, Australia., Wang Z; Department of Internal Medicine - Oncology, Shandong Cancer Hospital & Institute, Jinan, China., Liu Y; Department of Medical Oncology, The First Hospital of China Medical University, Shenyang, China., Li H; BeiGene (Shanghai) Co., Ltd, Shanghai, China., Zhang J; BeiGene (Beijing) Co., Ltd, Beijing, China., Peng Y; BeiGene (Shanghai) Co., Ltd, Shanghai, China., Wu YL; Guangdong Lung Cancer Institute, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Guangzhou, China syylwu@live.cn.

المصدر: Journal for immunotherapy of cancer [J Immunother Cancer] 2023 Feb; Vol. 11 (2).

نوع المنشور: Clinical Trial, Phase I; Multicenter Study; Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: BMJ Publishing Group Ltd Country of Publication: England NLM ID: 101620585 Publication Model: Print Cited Medium: Internet ISSN: 2051-1426 (Electronic) Linking ISSN: 20511426 NLM ISO Abbreviation: J Immunother Cancer Subsets: MEDLINE

مواضيع طبية MeSH: Carcinoma, Non-Small-Cell Lung*/drug therapy , Crocus*/metabolism , Lung Neoplasms*/drug therapy, Humans ; B7-H1 Antigen

المؤلفون: Shi Y; Department of Medical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing Key Laboratory of Clinical Study on Anticancer Molecular Targeted Drugs, Beijing, People's Republic of China. Electronic address: syuankai@cicams.ac.cn., Wu S; Department of Respiratory Medicine, The First Hospital of Shanxi Medical Univers, Taiyuan, People's Republic of China., Wang K; Department of Respiratory and Critical Care Medicine, West China Hospital of Sichuan University, Chengdu, People's Republic of China., Cang S; Department of Medical Oncology, Henan Provincial People's Hospital, Zhengzhou, People's Republic of China., Yao W; Department of Medical Oncology, Sichuan Cancer Hospital, Chengdu, People's Republic of China., Fan Y; Department of Medical Oncology, Zhejiang Cancer Hospital, Hangzhou, People's Republic of China., Wu L; Department of Thoracic Medical Oncology, Hunan Cancer Hospital/The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha, People's Republic of China., Huang M; Department of Oncology, West China Hospital of Sichuan University, Chengdu, People's Republic of China., Li X; Department of Oncology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, People's Republic of China., Pan Y; Department of Thoracic Cancer Chemotherapy, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, People's Republic of China., Yang Z; Cancer Center, Affiliated Hospital of Guangdong Medical University, Zhanjiang, People's Republic of China., Zhu B; Department of Oncology, Institute of Cancer, Xinqiao Hospital, Third Military Medical University, Chongqing, People's Republic of China., Chen G; Department of Respiratory Medicine, Harbin Medical University Cancer Hospital, Harbin, People's Republic of China., Shi J; Department of Medical Oncology, Linyi Cancer Hospital, Linyi, People's Republic of China., Sun M; Department of Oncology, Ji'nan Central Hospital Shandong University, Jinan, People's Republic of China., Fang J; Department of Thoracic Oncology, Beijing Cancer Hospital, Beijing, People's Republic of China., Wang L; Cancer Center, The Second Affiliated Hospital of Xingtai Medical College, Xingtai, People's Republic of China., Chen Z; Department of Oncology, People's Hospital of Deyang City, Deyang, People's Republic of China., Liu C; Pulmonary Cancer Medicine, Affiliated Tumor Hospital of Xinjiang Medical University, Urumqi, People's Republic of China., Li J; Department of Oncology, Liuzhou People's Hospital, Liuzhou, People's Republic of China., Liu J; Department of Oncology, The First Affiliated Hospital of Dalian Medical University, Dalian, People's Republic of China., Sun S; Department of Respiratory Medicine, Third Xiangya Hospital of Central South University, Changsha, People's Republic of China., Zhao Y; Department of Respiratory Medicine, The Affiliated Cancer Hospital of Zhengzhou University, Zhengzhou, People's Republic of China., Guo Y; Department of Medical Oncology, The First Affiliated Hospital of Henan University of Science & Technology, Luoyang, People's Republic of China., Meng Z; Department of Respiratory Medicine, The Affiliated Huai'an No. 1 People's Hospital of Nanjing Medical University, Huai'an, People's Republic of China., Liu Z; Department of Oncology, Chinese PLA General Hospital, Beijing, People's Republic of China., Han Z; Pulmonary Cancer Medicine, Affiliated Tumor Hospital of Xinjiang Medical University, Urumqi, People's Republic of China., Lu H; Department of Oncology, Huaihe Hospital of Henan University, Kaifeng, People's Republic of China., Ma R; Department of Thoracic Oncology, Liaoning Cancer Hospital & Institute, Shenyang, People's Republic of China., Hu S; Department of Thoracic Oncology, Hubei Cancer Hospital, Wuhan, People's Republic of China., Zhao G; Department of Thoracic Surgery, Hwa Mei Hospital, University of Chinese Academy of Sciences, Ningbo, People's Republic of China., Liu Z; Department of Oncology, Handan Central Hospital, Handan, People's Republic of China., Xie C; Department of Radiotherapy, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, People's Republic of China., Zhong D; Department of Medical Oncology, Tianjin Medical University General Hospital, Tianjin, People's Republic of China., Zhao H; Department of Respiratory Medicine, The Second Hospital of Anhui Medical University, Hefei, People's Republic of China., Yu H; Department of Palliative Care, Department of Geriatric Oncology, Chongqing University Cancer Hospital, Chongqing, People's Republic of China., Zhang L; Department of Radiotherapy, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, People's Republic of China., Bi M; Department of Medical Oncology, The First Affiliated Hospital of Bengbu Medical College, Bengbu, People's Republic of China., Yi S; Department of Medical Oncology, Zhengzhou Central Hospital Affiliated to Zhengzhou University, Zhengzhou, People's Republic of China., Guo S; Department of Respiratory Medicine, The First Affiliated Hospital of Chongqing Medical University, Chongqing, People's Republic of China., Yi T; Department of Oncology, Xiangyang Central Hospital, Affiliated Hospital of Hubei University of Arts and Sciences, Xiangyang, People's Republic of China., Li W; Department of Respiratory and Critical Care Medicine, The Second Affiliated Hospital Zhejiang University School of Medicine, Hangzhou, People's Republic of China., Lin Y; Department of Medical Oncology, Cancer Hospital of Shantou University Medical College, Shantou, People's Republic of China., Shu Y; Department of Oncology, Jiangsu Province Hospital, Nanjing, People's Republic of China., Chen Z; Department of Oncology, The Second Hospital of Anhui Medical University, Hefei, People's Republic of China., Guo Z; Department of Respiratory Medicine, Shanghai East Hospital, Shanghai, People's Republic of China., Greco M; Department of Drug Discovery, Beta Pharma Inc., Princeton, New Jersey., Wang T; Department of Clinical Development, Beta Pharma (Shanghai) Co., Ltd., Shanghai, People's Republic of China., Shen H; Department of Clinical Development, Beta Pharma (Shanghai) Co., Ltd., Shanghai, People's Republic of China.

المصدر: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer [J Thorac Oncol] 2022 Nov; Vol. 17 (11), pp. 1306-1317. Date of Electronic Publication: 2022 Aug 29.

نوع المنشور: Clinical Trial, Phase II; Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Elsevier Country of Publication: United States NLM ID: 101274235 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1556-1380 (Electronic) Linking ISSN: 15560864 NLM ISO Abbreviation: J Thorac Oncol Subsets: MEDLINE

مواضيع طبية MeSH: Antineoplastic Agents*/pharmacology , Antineoplastic Agents*/therapeutic use , Carcinoma, Non-Small-Cell Lung*/drug therapy , Carcinoma, Non-Small-Cell Lung*/genetics , Carcinoma, Non-Small-Cell Lung*/pathology , Lung Neoplasms*/drug therapy , Lung Neoplasms*/genetics , Lung Neoplasms*/pathology, Humans ; ErbB Receptors ; Mutation ; Neoplasm Recurrence, Local/drug therapy ; Neoplasm Recurrence, Local/genetics ; Protein Kinase Inhibitors/pharmacology ; Protein Kinase Inhibitors/therapeutic use

المؤلفون: Lu S; Department of Medical Oncology, Shanghai Chest Hospital, Shanghai JiaoTong University, Shanghai, China., Dong X; Cancer Center, Union Hospital Tongji Medical College Huazhong University of Science and Technology, Wuhan, China., Jian H; Department of Medical Oncology, Shanghai Chest Hospital, Shanghai JiaoTong University, Shanghai, China., Chen J; Department of Medical Oncology-Chest, Hunan Cancer Hospital & The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha, China., Chen G; Thoracic Oncology Medicine, Harbin Medical University Cancer Hospital, Harbin, China., Sun Y; Department of Oncology, Jinan Central Hospital, Jinan, China., Ji Y; Department of Oncology, First Affiliated Hospital of Xinxiang Medical University, Xinxiang, China., Wang Z; Department of Chest Medicine, Beijing Cancer Hospital, Beijing, China., Shi J; Department of Internal Medicine, Linyi Cancer Hospital, Linyi, China., Lu J; Departments of Respiratory Medicine, Nantong Tumor Hospital, Nantong, China., Chen S; Department of Oncology, Binzhou Medical University Hospital, Binzhou, China., Lv D; Breath Internal Medicine, Taizhou Hospital of Zhejiang Province, Linhai, China., Zhang G; Department of Respiration, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China., Liu C; Department of Lung Internal Medicine, Affiliated Tumor Hospital of Xinjiang Medical University, Urumqi, China., Li J; Department of Thoracic Oncology, Sichuan Cancer Hospital, Chengdu, China., Yu X; Thoracic Medical Oncology, Cancer Hospital of the University of Chinese Academy of Sciences (Zhejiang Cancer Hospital), Hangzhou, China., Lin Z; Department of Thoracic Oncology, The Fifth Subsidiary Sun Yat-sen University Hospital, Zhuhai, China., Yu Z; Department of Oncology, The Affiliated Hospital of Qingdao University, Qingdao, China., Wang Z; Department of Oncology, Shandong Cancer Hospital, Jinan, China., Cui J; Department of Oncology, The First Bethune Hospital of Jilin University, Changchun, China., Xu X; Department of Respiration, Northern Jiangsu People's Hospital, The Affiliated Hospital to Yangzhou University, Yangzhou, China., Fang J; Department of Chest Medicine, Beijing Cancer Hospital, Beijing, China., Feng J; Department of Internal Medicine, Jiangsu Cancer Hospital, Jiangsu Institute of Cancer Research, The Affiliated Cancer Hospital of Nanjing Medical University, Nanjing, China., Xu Z; Department of Respiration, Xinqiao Hospital, The Second Affiliated Hospital of China PLA Army Medical University, Chongqing, China., Ma R; Department of Chest Internal Medicine, Liaoning Cancer Hospital & Institute, Shenyang, China., Hu J; Respiratory Medicine, Zhongshan Hospital, Fudan University, Shanghai, China., Yang N; Lung & Gastrointestinal Oncology Department, Hunan Cancer Hospital (The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University), Changsha, China., Zhou X; Department of Respiratory and Critical Care Medicine, the Southwest Hospital of AMU, The First Affiliated Hospital of PLA Army Medical University, Chongqing, China., Wu X; Department of Oncology, Affiliated Hospital of Jiangnan University, Wuxi, China., Hu C; Respiratory Medicine, Xiangya Hospital Central South University, Changsha, China., Zhang Z; Department of Respiration Oncology, Anhui Provincial Cancer Hospital, Hefei, China., Lu Y; Department of Thoracic Oncology, West China Hospital of Sichuan University, Chengdu, China., Hu Y; Department of Thoracic Oncology, Hubei Cancer Hospital, Wuhan, China., Jiang L; Department of Respiration, Shanghai Chest Hospital, Shanghai JiaoTong University, Shanghai, China., Wang Q; Department of Respiration, Henan Cancer Hospital, Zhengzhou, China., Guo R; Department of Oncology, Jiangsu Province Hospital, Nanjing, China., Zhou J; Department of Respiratory Medicine, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China., Li B; Department of Oncology Internal Medicine, Beijing Chest Hospital, Capital Medical Hospital, Beijing, China., Hu C; Department of Oncology, Xiangya Second Hospital of Central South University, Changsha, China., Tong W; Department of Infection Internal Medicine, Nanfang Hospital, Nanfang Medical University, Guangzhou, China., Zhang H; Department of Oncology, The Second Affiliated Hospital of Air Force Military Medical University, Xi'An, China., Ma L; Department of Respiration, The First Affiliated Hospital of Nanchang University, Nanchang, China., Chen Y; Department of Oncology, Tongji Medical College Huazhong University of Science & Technology, Wuhan, China., Jie Z; Department of Respiratory and Critical Care Medicine, Shanghai Fifth People's Hospital, Fudan University Shanghai, China., Yao Y; Department of Oncology Internal Medicine, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'An, China., Zhang L; Radiotherapy Department, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, China., Jie W; Department of Oncology, Yueyang Central Hospital, Yueyang, China., Li W; Department of Internal Medicine, Affiliated Cancer Hospital and Institute of Guangzhou Medical University, Guangzhou, China., Xiong J; Department of Oncology, The First Affiliated Hospital of Nanchang University, Nanchang, China., Ye X; Department of Respiratory and Critical Care Medicine, GuiZhou Provincial People's Hospital, Guiyang, China., Duan J; Department of Internal Medicine, Cancer Hospital Chinese Academy of Medical Sciences, Beijing, China., Yang H; Radiotherapy Section, Taizhou Hospital of Zhejiang Province, Linhai, China., Sun M; Department of Oncology Internal Medicine, Jinan Central Hospital Affiliated to Shandong University, Jinan, China., Sun C; Hansoh Pharmaceutical Group Co. Ltd, Shanghai, China., Wei H; Hansoh Pharmaceutical Group Co. Ltd, Shanghai, China., Li C; Hansoh Pharmaceutical Group Co. Ltd, Shanghai, China., Ali SM; EQRx, Inc, Cambridge, MA., Miller VA; EQRx, Inc, Cambridge, MA., Wu Q; Hansoh Pharmaceutical Group Co. Ltd, Shanghai, China.

المصدر: Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2022 Sep 20; Vol. 40 (27), pp. 3162-3171. Date of Electronic Publication: 2022 May 17.

نوع المنشور: Clinical Trial, Phase III; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 8309333 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1527-7755 (Electronic) Linking ISSN: 0732183X NLM ISO Abbreviation: J Clin Oncol Subsets: MEDLINE

مواضيع طبية MeSH: Carcinoma, Non-Small-Cell Lung*/drug therapy , Carcinoma, Non-Small-Cell Lung*/genetics , Carcinoma, Non-Small-Cell Lung*/pathology , Lung Neoplasms*/drug therapy , Lung Neoplasms*/genetics , Lung Neoplasms*/pathology , Small Cell Lung Carcinoma*/drug therapy, Acrylamides ; Disease-Free Survival ; ErbB Receptors/genetics ; Exons ; Gefitinib/therapeutic use ; Humans ; Indoles ; Mutation ; Protein Kinase Inhibitors/adverse effects ; Pyrimidines ; Quinazolines/therapeutic use